BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20175992)

  • 21. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
    Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
    Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequestering of p53 into DNA-protein filaments revealed by electron microscopy.
    Cherny DI; Brázdova M; Palecek J; Palecek E; Jovin TM
    Biophys Chem; 2005 Apr; 114(2-3):261-71. PubMed ID: 15829361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of DNA Supercoiling Induced by DNA-Protein Interactions.
    Clark DJ; Leblanc BP
    Methods Mol Biol; 2015; 1334():161-72. PubMed ID: 26404149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ethidium binding and superhelix density on the supercoiling free energy and torsion and bending constants of p30 delta DNA.
    Clendenning JB; Naimushin AN; Fujimoto BS; Stewart DW; Schurr JM
    Biophys Chem; 1994 Nov; 52(3):191-218. PubMed ID: 7999972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two superhelix density-dependent DNA transitions detected by changes in DNA adsorption/desorption behavior.
    Fojta M; Bowater RP; Stanková V; Havran L; Lilley DM; Palecek E
    Biochemistry; 1998 Apr; 37(14):4853-62. PubMed ID: 9538002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavopiridol binds to duplex DNA.
    Bible KC; Bible RH; Kottke TJ; Svingen PA; Xu K; Pang YP; Hajdu E; Kaufmann SH
    Cancer Res; 2000 May; 60(9):2419-28. PubMed ID: 10811119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid method for the measurement of the unwinding angle of intercalating agents and the superhelix density of circular DNAs.
    Lee JS; Morgan AR
    Nucleic Acids Res; 1978 Jul; 5(7):2425-39. PubMed ID: 209409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of threading intercalators to target DNA.
    Howell LA; Gulam R; Mueller A; O'Connell MA; Searcey M
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6956-9. PubMed ID: 20980148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varying levels of positive and negative supercoiling differently affect the efficiency with which topoisomerase II catenates and decatenates DNA.
    Roca J
    J Mol Biol; 2001 Jan; 305(3):441-50. PubMed ID: 11152602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformation and rigidity of DNA microcircles containing waf1 response element for p53 regulatory protein.
    Zhou H; Zhang Y; Ou-Yang Z; Lindsay SM; Feng XZ; Balagurumoorthy P; Harrington RE
    J Mol Biol; 2001 Feb; 306(2):227-38. PubMed ID: 11237596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA bending due to specific p53 and p53 core domain-DNA interactions visualized by electron microscopy.
    Cherny DI; Striker G; Subramaniam V; Jett SD; Palecek E; Jovin TM
    J Mol Biol; 1999 Dec; 294(4):1015-26. PubMed ID: 10588903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence.
    Niewolik D; Vojtesek B; Kovarik J
    Oncogene; 1995 Mar; 10(5):881-90. PubMed ID: 7898929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleosome dynamics V. Ethidium bromide versus histone tails in modulating ethidium bromide-driven tetrasome chiral transition. A fluorescence study of tetrasomes on DNA minicircles.
    Sivolob A; Prunell A
    J Mol Biol; 2000 Jan; 295(1):41-53. PubMed ID: 10623507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism.
    Hainaut P; Rolley N; Davies M; Milner J
    Oncogene; 1995 Jan; 10(1):27-32. PubMed ID: 7824276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthraquinones quinizarin and danthron unwind negatively supercoiled DNA and lengthen linear DNA.
    Verebová V; Adamcik J; Danko P; Podhradský D; Miškovský P; Staničová J
    Biochem Biophys Res Commun; 2014 Jan; 444(1):50-5. PubMed ID: 24434150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
    Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
    Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.